EGFR-modified bacterial minicells loaded with siRNA could validly knock down the expression of PLK1, KSP, CDK1, and have the excellent ability to suppress tumor cell proliferation in HCT116 tumor-bearing mice. Here, PLK1 is linked to neoplasm.